Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
3,219
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

Maen Abdelrahima Institute of Academic Medicine and Weill Cornell Medical College, Houston Methodist Cancer Center, Houston, Texas, USAView further author information
,
Omar Mamloukb Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
,
Heather Linc Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
,
Jamie Linb Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
,
Valda Pageb Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
,
Noha Abdel-Wahabd Rheumatology and Rehabilitation Department, Assiut University Hospitals, Faculty of Medicine, Assiut, Egypt;e Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;f Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
,
Joshua Swang Department of System Pharmacy, Houston Methodist, Houston, Texas, USAView further author information
,
Umut Selameth Division of Renal Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USAView further author information
,
Cassian Yeef Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
,
Adi Diabf Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
,
Wadi Sukii Department of Medicine, Nephrology, Houston Methodist Hospital, Houston, Texas, USAView further author information
&
Ala Abudayyehb Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USACorrespondence[email protected]
View further author information
 show all
Article: 1927313 | Received 19 Feb 2021, Accepted 04 May 2021, Published online: 23 May 2021

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Swati Mishra, Vishwadeep Shelke, Neha Dagar, Maciej Lech & Anil Bhanudas Gaikwad. (2024) Immunosuppressants against acute kidney injury: what to prefer or to avoid?. Immunopharmacology and Immunotoxicology 0:0, pages 1-14.
Read now
Zhongke Qin, Kang Liu, Xueqiang Xu, Ting Li, Yifei Ge, Buyun Wu, Changying Xing & Huijuan Mao. (2022) Incidence, Predictors and 6-Month Overall Outcome of Acute Kidney Injury in Chinese Patients Receiving PD-1 Inhibitors. Future Oncology 18:16, pages 1951-1962.
Read now

Articles from other publishers (24)

Minoru Sakuragi, Eiichiro Uchino, Noriaki Sato, Takeshi Matsubara, Akihiko Ueda, Yohei Mineharu, Ryosuke Kojima, Motoko Yanagita & Yasushi Okuno. (2024) Interpretable machine learning-based individual analysis of acute kidney injury in immune checkpoint inhibitor therapy. PLOS ONE 19:3, pages e0298673.
Crossref
Arjunmohan Mohan, Pajaree Krisanapan, Supawit Tangpanithandee, Charat Thongprayoon, Swetha Rani Kanduri, Wisit Cheungpasitporn & Sandra M. Herrmann. (2024) Association of Proton Pump Inhibitor Use and Immune Checkpoint Inhibitor-Mediated Acute Kidney Injury: A Meta-Analysis and a Review of Related Outcomes. American Journal of Nephrology, pages 1-11.
Crossref
Jennifer Panich, Craig Irwin, Adam Bissonette, Sabri Elkhidir, Fahad Lodhi, Connie Folz, Joshua Lee, Soumya Pulipati, Zebi Fatima, Prathima Gopinath, Rebecca Blonsky, Chady Abboud Leon & Siddhartha Kattamanchi. (2023) Cohort study on immune checkpoint inhibitor-associated acute kidney injury: Incidence, risk factors, and management strategies. Journal of Oncology Pharmacy Practice 30:2, pages 286-294.
Crossref
Ping Zhou, Ying Gao, Zhijuan Kong, Junlin Wang, Shuxuan Si, Wei Han, Jie Li, Zhimei Lv & Rong Wang. (2024) Immune checkpoint inhibitors and acute kidney injury. Frontiers in Immunology 15.
Crossref
Jia-Jin Chen, Tao-Han Lee, George Kuo, Chieh-Li Yen, Cheng-Chia Lee, Chih-Hsiang Chang, Kun-Hua Tu, Yung-Chang Chen, Ji-Tseng Fang, Cheng-Chieh Hung, Chih-Wei Yang, Wen-Chi Chou, Ching-Chi Chi, Yu-Kang Tu & Huang- Yu Yang. (2024) All-cause and immune checkpoint inhibitor–associated acute kidney injury in immune checkpoint inhibitor users: a meta-analysis of occurrence rate, risk factors and mortality. Clinical Kidney Journal 17:1.
Crossref
Isaac Goncalves, Cameron Lewis, Brian Grainger, Rebecca Dring, Nora Lee, Sant-Rayn Pasricha, Jeffrey Szer & Kylie Mason. (2024) Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes. Research and Practice in Thrombosis and Haemostasis 8:1, pages 102342.
Crossref
Jiyu Tang, Nan Yang, Shujun Pan, Peiyao Ren, Maosheng Chen, Juan Jin, Qiang He & Yuqun Zeng. (2023) The renal damage and mechanisms relevant to antitumoral drugs. Frontiers in Oncology 13.
Crossref
Vishnupriyadevi Parvathareddy, Umut Selamet, Aditi A. Sen, Omar Mamlouk, Juhee Song, Valda D. Page, Maen Abdelrahim, Adi Diab, Noha Abdel-Wahab & Ala Abudayyeh. (2023) Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response. Cancers 15:21, pages 5181.
Crossref
Wenhui Xie, Shiyu Xiao, Xiaoyuan Li, Jing Huang, Guangtao Li & Zhuoli Zhang. (2023) Incidence, mortality, and risk factors of acute kidney injury after immune checkpoint inhibitors: Systematic review and meta-analysis of real-world evidence. European Journal of Internal Medicine 115, pages 88-95.
Crossref
Nuttha Lumlertgul, Pietro Vassallo, Florence Tydeman, Natasha Lewis, Abigail Hobill, Kittisak Weerapolchai, Nurul Zaynah Nordin, Nina Seylanova, Luke Martin, Armando Cennamo, Yanzhong Wang, Anne Rigg, Nisha Shaunak & Marlies Ostermann. (2023) Acute kidney injury in patients receiving immune checkpoint inhibitors: a retrospective real-world study. European Journal of Cancer 191, pages 112967.
Crossref
Sehrish Qureshi, Naszrin Arani, Vishnu Parvathareddy, Amanda Tchakarov, Maen Abdelrahim, Maria Suarez-Almazor, Jianjun Zhang, Don Lynn Gibbons, John Heymach, Mehmet Altan & Ala Abudayyeh. (2023) Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab. Frontiers in Nephrology 3.
Crossref
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, Alberto G. Agostara, Sara Oresti, Annalisa Zeppellini, Laura Giannetta, Giulio Cerea, Diego Signorelli, Salvatore Siena & Andrea Sartore-Bianchi. (2023) Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity. Cancer Research 83:14, pages 2283-2296.
Crossref
Caihong Liu, Wei Wei, Letian Yang, Jian Li, Cheng Yi, Yajun Pu, Ting Yin, Feifei Na, Ling Zhang, Ping Fu & Yuliang Zhao. (2023) Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Frontiers in Immunology 14.
Crossref
Pengwei Chen, Jianhong Zhu, Yanchun Xu, Qiuyan Huang, Jianan Su, Ziqing Gao & Min Feng. (2023) Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database. BMC Nephrology 24:1.
Crossref
Fei Liu, Zixian Wang, Xiaofan Li, Zhen Zhang, Yue Yang, Junquan Chen, Dinghua Chen, Lingling Wu, Xiangyu Liu, Sujun Han, Fangming Wang, Wasilijiang Wahafu, Yibo Gao, Shancheng Ren, Nianzeng Xing, Guangyan Cai & Xiangmei Chen. (2022) Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors. Cancer Communications 43:2, pages 214-224.
Crossref
Adrien Joseph, Antoine Lafarge, Elie Azoulay & Lara Zafrani. (2022) Acute Kidney Injury in Cancer Immunotherapy Recipients. Cells 11:24, pages 3991.
Crossref
Ben Sprangers, David E. Leaf, Camillo Porta, Maria José Soler & Mark A. Perazella. (2022) Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury. Nature Reviews Nephrology 18:12, pages 794-805.
Crossref
Jianhong Zhu, Jialing Wu, Pengwei Chen, Kaiyun You, Jianan Su, Ziqing Gao, Zhuofei Bi & Min Feng. (2022) Acute kidney injury associated with immune checkpoint inhibitors: A pharmacovigilance study. International Immunopharmacology 113, pages 109350.
Crossref
Ming-Su Ji, Rilige Wu, Zhe Feng, Yuan-Da Wang, Yong Wang, Li Zhang, Xue-Feng Sun, Xiang-Mei Chen, Kun-Lun He & Guang-Yan Cai. (2022) Incidence, risk factors and prognosis of acute kidney injury in patients treated with immune checkpoint inhibitors: a retrospective study. Scientific Reports 12:1.
Crossref
Harish Seethapathy, Sandra M. Herrmann & Arash Rashidi. (2022) Immune Checkpoint Inhibitor–Associated AKI: Debates in Diagnosis, Management, and Rechallenge. Seminars in Nephrology 42:6, pages 151346.
Crossref
Ala Abudayyeh, Liye Suo, Heather Lin, Omar Mamlouk, Noha Abdel-Wahab & Amanda Tchakarov. (2022) Pathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor–Induced Kidney Injury. Cancers 14:21, pages 5267.
Crossref
Muhammad O. Awiwi, Ala Abudayyeh, Noha Abdel-Wahab, Adi Diab, Migena Gjoni, Guofan Xu, Raghu Vikram & Khaled Elsayes. (2022) Imaging features of immune checkpoint inhibitor-related nephritis with clinical correlation: a retrospective series of biopsy-proven cases. European Radiology 33:3, pages 2227-2238.
Crossref
Shane S. Scott, Ashley N. Greenlee, Ethan J. Schwendeman, Somayya J. Mohammad, Michael T. Naughton, Anna Matzko, Mamadou Diallo, Matthew Stein, Rohith Revan, Taborah Z. Zaramo, Gabriel Shimmin, Shwetabh Tarun, Joel Ferrall, Thai H. Ho & Sakima A. Smith. 2022. Cardiovascular Signaling in Health and Disease. Cardiovascular Signaling in Health and Disease 111 173 .
Omar Mamlouk, Jamie S. Lin & Ala Abudayyeh. 2022. Managing Immunotherapy Related Organ Toxicities. Managing Immunotherapy Related Organ Toxicities 197 214 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.